Mortality following bone metastasis and skeletal-related events among women with breast cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 231-238

  Sathiakumar, Nalini ^a   Delzell, Elizabeth ^a   Morrisey, Michael A ^a   Falkson, Carla ^b   Yong, Mellissa ^c   Chia, Victoria ^c   Blackburn, Justin ^a   Arora, Tarun ^a   Brill, Ilene ^a   Kilgore, Meredith L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c AMGEN INC   (United States)

Author keywords

Bone metastasis; Breast cancer; Medicare beneficiaries; Skeletal related events

Indexed keywords

AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MEDICARE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 84856234931     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1721-x     Document Type: Article

References (32)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds) (2009) SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda
2. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (2009) SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda. http://seer.cancer.gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site
3. Ries, LAG, Eisner MP, Kosary CL (2002) SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1973- 1999/. Accessed 25 Aug 2010
4. R Yancik LG Ries JW Yates 1989 Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival Cancer 63 976 981 2914302 10.1002/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3. 0.CO;2-A 1:STN:280:DyaL1M7hvFCjsw%3D%3D (Pubitemid 19063212)
5. American Cancer Society Breast Cancer Facts & Figures 2009-2010. Atlanta, GA: 2010. www.cancer.org/acs/groups/content/@nho/documents/document/ f861009final90809pdf.pdf. Accessed 25 Aug 2010
6. V Scheid AU Buzdar TL Smith GN Hortobagyi 1986 Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy Cancer 58 2589 2593 3779609 10.1002/1097-0142(19861215)58:12<2589::AID- CNCR2820581206>3.0.CO;2-O 1:STN:280:DyaL2s%2FltFansQ%3D%3D (Pubitemid 17232912)
7. RE Coleman 2006 Clinical features of metastatic bone disease and risk of skeletal morbidity Clin Cancer Res 12 6243s 6249s 17062708 10.1158/1078-0432. CCR-06-0931 (Pubitemid 44703797)
8. KP Weinfurt LD Castel Y Li JW Timbie GA Glendenning KA Schulman 2004 Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions Med Care 42 164 175 14734954 10.1097/01.mlr.0000108746.69256.45
9. C Bouchardy E Rapiti S Blagojevic AT Vlastos G Vlastos 2007 Older female cancer patients: importance, causes, and consequences of undertreatment J Clin Oncol 25 14 1858 1869 17488984 10.1200/JCO.2006.10.4208 (Pubitemid 46854419)
10. S Eaker PW Dickman L Bergkvist L Holmberg 2006 Uppsala/Orebro Breast Cancer Group. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden PLoS Med 3 3 e25 16409108 10.1371/journal.pmed.0030025
11. SM Enger SS Thwin DS Buist T Field F Frost AM Geiger TL Lash M Prout MU Yood F Wei RA Silliman 2006 Breast cancer treatment of older women in integrated health care settings J Clin Oncol 24 27 4377 4383 16983106 10.1200/JCO.2006.06. 3065 (Pubitemid 46630974)
12. G Kimmick HB Muss 2004 Breast cancer in older patients Semin Oncol 31 234 248 15112153 10.1053/j.seminoncol.2003.12.033 (Pubitemid 38481242)
13. M Yong AO Jensen JB Jacobson M Norgaard JP Fryzek HT Sorensen 2009 Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007) J Clin Oncol 27 e22210
14. AL Potosky GF Riley JD Lubitz RM Mentnech LG Kessler 1993 Potential for cancer related health services research using a linked medicare-tumor registry database Med Care 31 732 748 8336512 10.1097/00005650-199308000-00006 1:STN:280:DyaK3szivF2hsA%3D%3D
15. JL Warren CN Klabunde D Schrag PB Bach GF Riley 2002 Overview of the SEER-medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 IV-3-18 12187163
16. ME Gornick JL Warren PW Eggers, et al. 1996 Thirty years of medicare: impact on the covered population Health Care Financ Rev 18 179 237 10173021 1:STN:280:DyaK2szjvFeqsQ%3D%3D
17. PS Romano LL Roos JG Jollis 1993 Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives J Clin Epidemiol 46 1075 1079 8410092 10.1016/0895-4356(93)90103-8 1:STN:280: DyaK2c%2FhsFWrsw%3D%3D discussion 81-90 (Pubitemid 23302074)
18. H Quan V Sundararajan P Halfon, et al. 2005 Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 1130 1139 16224307 10.1097/01.mlr.0000182534.19832.83 (Pubitemid 41587600)
19. TA Gooley W Leisenring J Crowley BE Storer 1999 Estimation of failure probabilities in the presence of competing risks: new representation of old estimators Stat Med 18 695 706 10204198 10.1002/(SICI)1097-0258(19990330)18: 6<695::AID-SIM60>3.0.CO;2-O 1:STN:280:DyaK1M3itVequw%3D%3D (Pubitemid 29126745)
20. Kalbfleish JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, New York
21. DR Cox 1972 Regression models and life-tables (with discussion) J Royal Stat Soc 34 187 220
22. SAS Institute Inc. Cary, NC, USA
23. GR Mundy 2002 Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 584 593 12154351 10.1038/nrc867 1:CAS:528:DC%2BD38XlslGqsLo%3D (Pubitemid 37328925)
24. RE Coleman RD Rubens 1987 The clinical course of bone metastases from breast cancer Br J Cancer 55 61 66 3814476 10.1038/bjc.1987.13 1:STN:280:DyaL2s7ivVOmug%3D%3D (Pubitemid 17234155)
25. AF Jacobson CL Shapiro AD Van den Abbeele WD Kaplan 2001 Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma Cancer 91 17 24 11148555 10.1002/1097-0142(20010101)91:1<17::AID-CNCR3>3.0.CO;2-K 1:STN:280:DC%2BD38%2Fgs1SlsQ%3D%3D (Pubitemid 32052609)
26. RE Coleman P Smith RD Rubens 1998 Clinical course and prognostic factors following bone recurrence from breast cancer Br J Cancer 77 336 340 9461007 10.1038/bjc.1998.52 1:STN:280:DyaK1c7itV2jtw%3D%3D (Pubitemid 28029553)
27. RE Coleman 1997 Skeletal complications of malignancy Cancer 80 1588 1594 9362426 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G 1:STN:280:DyaK1c%2Fis1Onuw%3D%3D (Pubitemid 27444031)
28. RE Coleman 2004 Bisphosphonates: clinical experience Oncologist 9 Suppl 4 14 27 15459426 10.1634/theoncologist.9-90004-14 1:CAS:528:DC%2BD2cXpslGhtbs%3D (Pubitemid 39363165)
29. F Saad A Lipton R Cook YM Chen M Smith R Coleman 2007 Pathologic fractures correlate with reduced survival in patients with malignant bone disease Cancer 110 1860 1867 17763372 10.1002/cncr.22991 (Pubitemid 47557312)
30. KO Rove ED Crawford 2009 Metastatic cancer in solid tumors and clinical outcome: skeletal-related events Oncology 23 14 21 27 20128325
31. A Lipton RL Theriault GN Hortobagyi, et al. 2000 Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials Cancer 88 1082 1090 10699899 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z 1:CAS:528:DC%2BD3cXhvFGhsL8%3D (Pubitemid 30127670)
32. LS Rosen D Gordon M Kaminski, et al. 2003 Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial Cancer 98 1735 1744 14534891 10.1002/cncr.11701 1:CAS:528:DC%2BD3sXovVCrsLw%3D (Pubitemid 37238631)